Cephalon Reinforces Important Prescribing And Dosing Information For FENTORA

Cephalon, Inc. (Nasdaq: CEPH) communicated with healthcare professionals to clarify the appropriate patient selection, dosing and administration for FENTORA(R) (fentanyl buccal tablet) [C-II]. The company is sharing this information with the medical community to reinforce the appropriate prescribing and use of the medication. The letter, issued in collaboration with the U.S. [click link for full article]

More: continued here

Filed under: Pain / Anesthetics on September 20th, 2007